by Jennifer Hill | Aug 5, 2026
Wiggin and Dana represented Wellinks in its recently announced $10 million Series B funding with participation from UMass Memorial Health and existing Wellinks investors. Wellinks is a leader in cardiopulmonary care, leveraging remote patient monitoring and predictive...
by Siena Mangi | Jul 30, 2026
Wiggin and Dana’s John Doroghazi, Josh Taylor, Chloe Booth, and Zachary Lee successfully obtained summary judgment on the vast majority of claims asserted against client Pike Fuels Limited Partnership in a closely watched environmental enforcement action brought...
by Gabrielle Giammattei | Jul 23, 2026
Wiggin and Dana is pleased to announce that the firm’s Private Client Services practice, along with Partners Michael T. Clear, Daniel L. Daniels, Jevera K. Hennessey, Leonard Leader, Vanessa L. Maczko, Steven B. Malech, Carolyn A. Reers, Matthew E. Smith, and...
by Siena Mangi | Jul 8, 2026
Wiggin and Dana is proud to announce that its Intellectual Property Practice Group has been selected by The New York Legal Awards as a finalist for Litigation Department of the Year: Intellectual Property. The firm’s Intellectual Property Practice Group provides...
by Tori Staniewicz | Jun 23, 2026
Wiggin and Dana recently represented BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) in connection with its research and collaboration agreement with Eli Lilly and Company regarding a potential new treatment combining BioArctic’s proprietary BrainTransporter™...
